Emerging Biotechnology Analyst Breidenbach, along with Dr. Debosch of Washington University, discuss new treatment options for recurrent C. difficile infection on an Analyst/Industry conference call to be held on February 1 at 10 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MCRB: